184 related articles for article (PubMed ID: 34852776)
1. Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions.
Jiang H; Meng L; Zhang H; Dai X; Zhang Q; Ju Z; Yu W; Ma L
BMC Cancer; 2021 Dec; 21(1):1284. PubMed ID: 34852776
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.
Khan AJ; Poppe MM; Goyal S; Kokeny KE; Kearney T; Kirstein L; Toppmeyer D; Moore DF; Chen C; Gaffney DK; Haffty BG
J Clin Oncol; 2017 Jun; 35(18):2037-2043. PubMed ID: 28459606
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer.
Tovanabutra C; Katanyoo K; Uber P; Chomprasert K; Sukauichai S
Asian Pac J Cancer Prev; 2020 Jan; 21(1):119-125. PubMed ID: 31983173
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
[TBL] [Abstract][Full Text] [Related]
5. Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity.
Chitapanarux I; Klunklin P; Pinitpatcharalert A; Sripan P; Tharavichitkul E; Nobnop W; Onchan W; Chakrabandhu S; Jia-Mahasap B; Euathrongchit J; Wannasopha Y; Srisuwan T
Radiat Oncol; 2019 Oct; 14(1):175. PubMed ID: 31610801
[TBL] [Abstract][Full Text] [Related]
6. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
Yadav BS; Sharma SC
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
De Matteis S; Facondo G; Valeriani M; Vullo G; De Sanctis V; Ascolese AM; Campanella B; Scalabrino G; Osti MF
Clin Breast Cancer; 2022 Apr; 22(3):e332-e340. PubMed ID: 34670727
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two hypofractionated radiotherapy schedules in locally advanced postmastectomy breast cancer patients.
Choudhary S; Gupta N; Misra S; Munnee NN; Kumar A; Ranjan R; Dhar SS; Kumar D; Mourya A; Aggarwal LM
J Cancer Res Ther; 2020; 16(6):1331-1335. PubMed ID: 33342792
[TBL] [Abstract][Full Text] [Related]
9. Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons.
Bradley JA; Dagan R; Ho MW; Rutenberg M; Morris CG; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):411-421. PubMed ID: 26611875
[TBL] [Abstract][Full Text] [Related]
10. 5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial.
Poppe MM; Yehia ZA; Baker C; Goyal S; Toppmeyer D; Kirstein L; Chen C; Moore DF; Haffty BG; Khan AJ
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):694-700. PubMed ID: 32289474
[TBL] [Abstract][Full Text] [Related]
11. Assessment of toxicities and outcomes in patients with breast cancer treated with hypofractionated radiotherapy.
Sindhu M; Malik M; Ahmed SF; Valiyaveettil D
Indian J Cancer; 2020; 57(4):423-427. PubMed ID: 33078749
[TBL] [Abstract][Full Text] [Related]
12. Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule: clinical and dosimetric outcomes.
Gadea J; Ortiz I; Roncero R; Alastuey I; Mestre F; Aymar N; Maturana JE; Garcia C; Mateu L; Pardo J
Clin Transl Oncol; 2021 Sep; 23(9):1915-1922. PubMed ID: 33830442
[TBL] [Abstract][Full Text] [Related]
13. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary-related patient-reported outcomes in a randomized clinical trial of radiation therapy for breast cancer.
Van Parijs H; Vinh-Hung V; Fontaine C; Storme G; Verschraegen C; Nguyen DM; Adriaenssens N; Nguyen NP; Gorobets O; De Ridder M
BMC Cancer; 2021 Nov; 21(1):1177. PubMed ID: 34736429
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.
Leite ETT; Ramos CCA; Ribeiro VAB; Salvajoli BP; Nahas WC; Salvajoli JV; Ynoe Moraes F
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1263-1270. PubMed ID: 33346091
[TBL] [Abstract][Full Text] [Related]
16. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
[TBL] [Abstract][Full Text] [Related]
19. Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review.
Liu L; Yang Y; Guo Q; Ren B; Peng Q; Zou L; Zhu Y; Tian Y
Radiat Oncol; 2020 Jan; 15(1):17. PubMed ID: 31952507
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated whole-breast radiation therapy: does breast size matter?
Hannan R; Thompson RF; Chen Y; Bernstein K; Kabarriti R; Skinner W; Chen CC; Landau E; Miller E; Spierer M; Hong L; Kalnicki S
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):894-901. PubMed ID: 22543209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]